RBR-73zrnjhNot yet recruiting未知
Efficacy of the use of oral N-acetylcysteine in the treatment of facial melasma in women: A randomized, double-blind, placebo-controlled clinical trial
Faculdade de Medicina de Botucatu (FMB - Unesp)0 sitesStarted: February 21, 2022Last updated:
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Not yet recruiting
- Sponsor
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Intervention
Eligibility Criteria
- Ages
- 18Y to 60Y (—)
- Sex
- Female
Inclusion Criteria
- •Women with facial melasma 18 to 60 years old, Fitzpatrick's phototypes II to V
Exclusion Criteria
- •Patients with other concomitant facial skin diseases, skin diseases with photosensitivity, melasma with mMASI less than 5, history of hypersensitivity to the active substance oral melatonin or to any other component of the formulation described, pregnant or lactating women.
Investigators
Similar Trials
Recruiting
Phase 3
Evaluation of oral N-acetylcysteine efficacy versus placebo in prevention of mucositis induced by radiotherapy and chemotherapy agents in children with malignancyIRCT20210622051666N1Ahvaz University of Medical Sciences80
Recruiting
Phase 2
Oral N-acetylcysteine (NAC) effectiveness in cystic fibrosis (CF)IRCT20090808002306N7Esfahan University of Medical Sciences45
Not yet recruiting
Phase 3
The effect of N-Acetylcysteine on COVID-19IRCT20200509047364N3Bandare-abbas University of Medical Sciences40
Recruiting
Phase 3
evaluation of N-acetylcysteine on nitrosative stress in Rheumatoid arthritis patientsIRCT2017073022965N12Vice Chancellor for research of Hamadan University of Medical Sciences52
Completed
Phase 4
The effect of oral N-acetylcysteine on quantitative serum high sensitivity CRP and hemoglobin in hemodialysis patientsEnd stage renal disease.End stage kidney diseaseN 18.5IRCT2016111030821N1Vice Chancellor for research of Ardabil University of Medical Sciences40